Madaus Inc: Clinical Trials

2 trials sponsored by Madaus Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 31Unknown 1

Follow Madaus Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Effects of Silymarin in Patients With B-thalassemia Major
Silymarin (LEGALON), Placebo - Beta-thalassemia Major, Iron Overload
Phase 2 / Phase 3UnknownIsfahan University of Medical Sciences1402009-03-012009-10-21
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Placebo, Silymarin 700 mg, Silymarin 420 mg - Non-alcoholic Steatohepatitis
Phase 2CompletedMadaus Inc782008-04-012019-07-17

Conditions studied

Iron Overload (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  beta-Thalassemia (1)

Interventions

Silymarin (2)  ·  Lactose (1)  ·  milk-thistle extract (1)

Countries

Iran (1)  ·  United States (1)

Top investigators

Behjat Moayedi, Professor (1)  ·  K. Rajender Reddy, MD (1)  ·  Michael Fried, MD (1)  ·  Nezam Afdhal, MD (1)  ·  Stephen A. Harrison, MD (1)  ·  Steven H. Belle, PhD (1)  ·  Victor Navarro, MD (1)

Results publications

PMID 31536511